New drugs developed by Beijing Medical University can resist 8 kinds of cancers.

The new anticancer drug "MPT0E028" developed by Taipei Medical College has been found to be effective in 8 kinds of cancers, including liver cancer, lung cancer, colorectal cancer, hematologic cancer's disease, lymphoma, pancreatic cancer, breast cancer and prostate cancer. At present, it has entered the first phase of clinical trials and is expected to enter the second phase of clinical trials next year. This new drug will be on the market in five years at the earliest. Pan, an associate professor in the doctoral program of tumor biology and drug research and development in Taipei Medical College, said that "MPT0E028" is a small molecule targeted drug, which can inhibit the activity of histone deacetylase (pan-HDAC) in cancer cells, enhance the effect of inhibiting the growth of cancer cells, and promote the apoptosis of cancer cells, greatly reducing the side effects such as vomiting, alopecia and low immunity. Pan stressed that animal experiments have proved that MPT0E028 can treat eight kinds of cancers, such as liver cancer, breast cancer, lung cancer, hematological tumor diseases, colorectal cancer and prostate cancer, and its inhibitory effect on cancer cells has increased from 50% to 75%, which is obviously superior to the existing traditional drugs. Liu Jingping, deputy dean of the School of Pharmacy, Taipei Medical College, pointed out that the drug has entered the first phase of clinical trials, obtained patents from Taiwan Province Province and the United States, and completed patent applications in the European Union, Russian Federation, Australia and other 19 countries and regions. It is expected to enter the second phase of clinical trials next year, and the new drug will be listed in five years at the earliest. Subscribe to the health Aloha audio-visual channel, read health knowledge more easily, and pay attention to your health every day! Line @ ID: @:/cancer/article/21203/Beijing Medical University develops new drugs against 8 kinds of cancer Keywords: liver cancer, colorectal cancer, small molecule targeted drugs, Pan, Beijing Medical University, breast cancer.